This week, four pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
- ADVERTISEMENT
-
-
Sponsored By:
- Poll of the Day
- Partners
- ADVERTISEMENT
BMY
Recent Articles
4 Pharmaceutical Stocks to Buy Now
Four pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
4 Pharmaceutical Stocks to Buy Now
The grades of four pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
5 Overpriced Stocks to Ditch Now
These stocks are either momentum darlings or supposed bastions of safety, but their valuations aren't justified. More
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
5 Pharmaceutical Stocks to Buy Now
The grades of five Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
